GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » ROE % Adjusted to Book Value

PELL Bio-Med Technology Co (TPE:6949) ROE % Adjusted to Book Value : -8.31% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is PELL Bio-Med Technology Co ROE % Adjusted to Book Value?

PELL Bio-Med Technology Co's ROE % for the quarter that ended in Dec. 2024 was -33.22%. PELL Bio-Med Technology Co's PB Ratio for the quarter that ended in Dec. 2024 was 4.00. PELL Bio-Med Technology Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -8.31%.


PELL Bio-Med Technology Co ROE % Adjusted to Book Value Historical Data

The historical data trend for PELL Bio-Med Technology Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PELL Bio-Med Technology Co ROE % Adjusted to Book Value Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
- - - -8.29

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -8.06 -5.10 -8.44 -8.31

Competitive Comparison of PELL Bio-Med Technology Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, PELL Bio-Med Technology Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PELL Bio-Med Technology Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PELL Bio-Med Technology Co's ROE % Adjusted to Book Value falls into.


;
;

PELL Bio-Med Technology Co ROE % Adjusted to Book Value Calculation

PELL Bio-Med Technology Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-33.14% / 4.00
=-8.29%

PELL Bio-Med Technology Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-33.22% / 4.00
=-8.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PELL Bio-Med Technology Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PELL Bio-Med Technology Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PELL Bio-Med Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).

PELL Bio-Med Technology Co Headlines

No Headlines